Edition:
United States

Ekso Bionics Holdings Inc (EKSO.OQ)

EKSO.OQ on NASDAQ Stock Exchange Capital Market

1.85USD
11:19am EDT
Change (% chg)

$-0.02 (-1.07%)
Prev Close
$1.87
Open
$1.87
Day's High
$1.87
Day's Low
$1.85
Volume
13,111
Avg. Vol
66,178
52-wk High
$4.76
52-wk Low
$1.03

Chart for

About

Ekso Bionics Holdings, Inc., formerly PN Med Group, Inc., designs, develops and sells wearable bionic human exoskeletons that have applications in healthcare, industrial, military and consumer markets. The Company operates through two segments: Engineering Services and Medical. The Engineering Services segment is engaged in... (more)

Overall

Beta: 1.18
Market Cap(Mil.): $107.43
Shares Outstanding(Mil.): 60.35
Dividend: --
Yield (%): --

Financials

  EKSO.OQ Industry Sector
P/E (TTM): -- 41.26 32.86
EPS (TTM): -0.68 -- --
ROI: -186.47 14.50 13.13
ROE: -426.89 17.67 15.07

BRIEF-Ekso Bionics Q1 Loss Per Share $0.13

* Q1 REVENUE ROSE 75 PERCENT TO $2.5 MILLION Source text for Eikon: Further company coverage:

May 07 2018

BRIEF-Ekso Bionics Holdings Q4 Revenue $2.5 Million

* EKSO BIONICS REPORTS FOURTH QUARTER AND YEAR END 2017 RESULTS

Mar 13 2018

BRIEF-Ekso Bionics Announces Executive Leadership Changes

* EKSO BIONICS ANNOUNCES EXECUTIVE LEADERSHIP CHANGES; JACK PEURACH, CO-FOUNDER OF EKSO BIONICS, LONG-TIME BOARD MEMBER AND SEASONED EXECUTIVE APPOINTED PRESIDENT AND CHIEF EXECUTIVE OFFICER; CHARLES LI, PH. D. TO JOIN BOARD OF DIRECTORS

Mar 12 2018

BRIEF-Ekso Bionics To Expand Clinical Trial Sites For Comparative Multicenter WISE Study

* EKSO BIONICS® TO EXPAND CLINICAL TRIAL SITES FOR COMPARATIVE MULTICENTER WISE STUDY

Feb 12 2018

Earnings vs. Estimates